Physician profile
Jay A Fleischman
NPI 1497750673
$2,608.55
in general payments reported to CMS, 2019-2025
16 companies · $1,059 in 2025
The $1,059 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2022: $108 · 2023: $24.33 · 2024: $849 · 2025: $1,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,782 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,781.73 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $829.29 | 2019-2025 | Eylea Hd, Eylea |
| Mallinckrodt Hospital Products INC. | $248.66 | 2024-2025 | Acthar |
| Alcon Vision LLC | $247.36 | 2025 | Tryptyr, Clareon Panoptix Pro |
| Bausch & Lomb Americas INC. | $231.40 | 2022-2025 | Xiidra, Miebo |
| Abbvie INC. | $229.65 | 2019-2025 | |
| Cardinal Health 110 LLC | $150.00 | 2024 | |
| Sight Sciences, INC. | $125.00 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Ani Pharmaceuticals, INC. | $120.17 | 2025 | Iluvien |
| Eyepoint US, INC. | $104.02 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $79.06 | 2019 | |
| Sun Pharmaceutical Industries INC. | $73.21 | 2019 | |
| Astellas Pharma US INC | $57.12 | 2024-2025 | Izervay |
| Amgen INC. | $41.51 | 2019 | |
| Oyster Point Pharma, INC. | $27.28 | 2024 | Ryzumvi, Tyrvaya |
| Calliditas Therapeutics US INC. | $24.47 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Fleischman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.